News/ News/ R&D Novo bolsters R&D pipeline with RNAi therapies from Dicerna Richard Staines Dicerna, NASH, Novo Nordisk, RNAi therapy 0 Comment Novo Nordisk has further bolstered its liver disease R&D pipeline, signing a deal with US biotech Dicerna to Share X Novo bolsters R&D pipeline with RNAi therapies from Dicerna https://pharmaphorum.com/news/novo-bolsters-rd-pipeline-with-rnai-therapies-from-dicerna/
